(15055031), A. E., (15055034), L. S., (15055037), S. I. V., (15055040), L. A. H., (14947288), C. A. L., (15055043), V. F., . . . (14947294), C. L. (2025). Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Čikaški stil citiranja (17. izdanje)(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.
MLA način citiranja (9. izdanje)(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.